{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:57Z","timestamp":1786993677192,"version":"build-2736575974"},"reference-count":245,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.lfs.2022.121332","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T20:49:13Z","timestamp":1672174153000},"page":"121332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections"],"prefix":"10.1016","volume":"314","author":[{"given":"Asmat","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Waris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ajmal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Asim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atta Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahrish","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehan","family":"Zeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lfs.2022.121332_bb0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41579-020-00507-2","article-title":"Cells within cells: rickettsiales and the obligate intracellular bacterial lifestyle","volume":"19","author":"Salje","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0010","series-title":"The Immune Response","first-page":"641","article-title":"Immunity to pathogens","author":"Mak","year":"2006"},{"key":"10.1016\/j.lfs.2022.121332_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fmicb.2011.00097","article-title":"Advances in genetic manipulation of obligate intracellular bacterial pathogens","volume":"2","author":"Beare","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftab052","article-title":"Keeping the host alive\u2013lessons from obligate intracellular bacterial pathogens","volume":"79","author":"Loterio","year":"2021","journal-title":"Pathog.Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1356540","article-title":"Intracellular pathogens: host immunity and microbial persistence strategies","volume":"2019","author":"Thakur","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.lfs.2022.121332_bb0030","series-title":"Semin. Cell Dev. Biol","first-page":"41","article-title":"Autophagy in intracellular bacterial infection","author":"Hu","year":"2020"},{"key":"10.1016\/j.lfs.2022.121332_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120344","article-title":"Antibacterial nanotruffles for treatment of intracellular bacterial infection","volume":"262","author":"Elnaggar","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.lfs.2022.121332_bb0040","series-title":"Myeloid Cells Heal.Dis. A Synth","first-page":"701","article-title":"Strategies used by bacteria to grow in macrophages","author":"Mitchell","year":"2017"},{"key":"10.1016\/j.lfs.2022.121332_bb0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.imbio.2012.05.011","article-title":"The in vivo extracellular life of facultative intracellular bacterial parasites: role in pathogenesis","volume":"218","author":"Silva","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.lfs.2022.121332_bb0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrmicro2012","article-title":"From bench to bedside: stealth of enteroinvasive pathogens","volume":"6","author":"Tsolis","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrmicro2351","article-title":"Carbon metabolism of intracellular bacterial pathogens and possible links to virulence","volume":"8","author":"Eisenreich","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrmicro2128","article-title":"Antimicrobial mechanisms of phagocytes and bacterial evasion strategies","volume":"7","author":"Flannagan","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0065","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/bph.13664","article-title":"Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections","volume":"174","author":"Kamaruzzaman","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.121332_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005083","article-title":"Intracellular uropathogenic E. coli exploits host Rab35 for iron acquisition and survival within urinary bladder cells","volume":"11","author":"Dikshit","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2022.121332_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-8-171","article-title":"A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells","volume":"8","author":"Garzoni","year":"2007","journal-title":"BMC Genomics"},{"key":"10.1016\/j.lfs.2022.121332_bb0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0882-4010(03)00112-8","article-title":"In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin-binding proteins","volume":"35","author":"Brouillette","year":"2003","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.lfs.2022.121332_bb0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41579-020-00507-2","article-title":"Cells within cells: rickettsiales and the obligate intracellular bacterial lifestyle","volume":"19","author":"Salje","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138830","article-title":"Rickettsia massiliae and Rickettsia conorii Israeli spotted fever strain differentially regulate endothelial cell responses","volume":"10","author":"Bechelli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121332_bb0095","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.cub.2006.06.060","article-title":"The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets","volume":"16","author":"Kumar","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.lfs.2022.121332_bb0100","article-title":"Immune response to mucosal brucella infection","volume":"1759","author":"L\u00f3pez-Santiago","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002769","article-title":"Linking the transcriptional profiles and the physiological states of Mycobacterium tuberculosis during an extended intracellular infection","volume":"8","author":"Rohde","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2022.121332_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1574-695X.1996.tb00242.x","article-title":"Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism","volume":"13","author":"T\u00e4rnvik","year":"1996","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0377-1237(04)80109-6","article-title":"HIV vaccine strategies\u2014an update","volume":"60","author":"Sahni","year":"2004","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.lfs.2022.121332_bb0120","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/pathogens10111353","article-title":"Recent progress in Shigella and Burkholderia pseudomallei vaccines","volume":"10","author":"Chapartegui-Gonz\u00e1lez","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.lfs.2022.121332_bb0125","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.drudis.2008.04.010","article-title":"Vaccines against intracellular bacterial pathogens","volume":"13","author":"Titball","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.lfs.2022.121332_bb0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.addr.2014.10.002","article-title":"Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges","volume":"93","author":"Tlaxca","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2022.121332_bb0135","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/microorganisms7110569","article-title":"A review of fish vaccine development strategies: conventional methods and modern biotechnological approaches","volume":"7","author":"Ma","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.lfs.2022.121332_bb0140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine adjuvants: from 1920 to 2015 and beyond","volume":"3","author":"DiPasquale","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.lfs.2022.121332_bb0145","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0169-409X(02)00072-8","article-title":"A strategic approach to vaccine development: animal models, monitoring vaccine efficacy, formulation and delivery","volume":"54","author":"Griffin","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2022.121332_bb0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/156802608783378864","article-title":"Recent developments in synthetic oligosaccharide-based bacterial vaccines","volume":"8","author":"Pozsgay","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.lfs.2022.121332_bb0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijmm.2007.08.004","article-title":"Vaccine protocols for enhanced immunogenicity of exogenous antigens","volume":"298","author":"Heit","year":"2008","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0160","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.1064571","article-title":"Priming of memory but not effector CD8 T cells by a killed bacterial vaccine","volume":"294","author":"Lauvau","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.lfs.2022.121332_bb0165","series-title":"Semin. Hematol","first-page":"4","article-title":"Fundamentals of the psoralen-based HelinxTM technology for inactivation of infectious pathogens and leukocytes in platelets and plasma","author":"Wollowitz","year":"2001"},{"key":"10.1016\/j.lfs.2022.121332_bb0170","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nm1276","article-title":"Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity","volume":"11","author":"Brockstedt","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2022.121332_bb0175","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nri1461","article-title":"Immune responses to Listeria monocytogenes","volume":"4","author":"Pamer","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.200205009","article-title":"The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity","volume":"158","author":"Portnoy","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2022.121332_bb0185","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1128\/IAI.67.11.5877-5884.1999","article-title":"Protection of mice against brucellosis by vaccination with Brucella melitensis WR201 (16M\u0394 purEK)","volume":"67","author":"Hoover","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb0190","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2567.2001.01258.x","article-title":"Interferon-\u03b3 is crucial for surviving a Brucella abortus infection in both resistant C57BL\/6 and susceptible BALB\/c mice","volume":"103","author":"Murphy","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2022.121332_bb0195","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.micinf.2010.10.015","article-title":"Cell-mediated immunity in human brucellosis","volume":"13","author":"Skendros","year":"2011","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2022.121332_bb0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jmii.2012.03.011","article-title":"Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum, and heat-killed Brucella melitensis 16 M","volume":"46","author":"Motaharinia","year":"2013","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.lfs.2022.121332_bb0205","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.micinf.2010.02.001","article-title":"Evaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, in combination with heat-killed Listeria monocytogenes vaccine","volume":"12","author":"Jazani","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2022.121332_bb0210","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1128\/JCM.37.6.1958-1963.1999","article-title":"Quantitative detection of Borrelia burgdorferi by real-time PCR","volume":"37","author":"Pahl","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0215","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.1128\/JVI.76.20.10524-10529.2002","article-title":"Evolutionary dynamics of viral attenuation","volume":"76","author":"Badgett","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2022.121332_bb0220","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-5-23","article-title":"Live bacterial vaccines\u2013a review and identification of potential hazards","volume":"5","author":"Detmer","year":"2006","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.lfs.2022.121332_bb0230","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1586\/14760584.6.3.431","article-title":"Live-attenuated salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?","volume":"6","author":"Lewis","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.lfs.2022.121332_bb0235","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nri819","article-title":"Cytotoxic T lymphocytes: all roads lead to death","volume":"2","author":"Barry","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/764542","article-title":"Induction of specific CD8+ T cells against intracellular bacteria by CD8+ T-cell-oriented immunization approaches","volume":"2010","author":"Nagata","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.lfs.2022.121332_bb0245","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/QCO.0000000000000475","article-title":"Recent insights into Shigella: a major contributor to the global diarrhoeal disease burden","volume":"31","author":"Baker","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb0250","first-page":"e1235","article-title":"Identification and management of shigella infection in children with diarrhoea: a systematic review and meta-analysis","volume":"5","author":"Tickell","year":"2017","journal-title":"LancetGlob. Health"},{"key":"10.1016\/j.lfs.2022.121332_bb0255","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2022.121332_bb0260","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/pathogens10091079","article-title":"Evaluation of a live attenuated S. sonnei vaccine strain in the human enteroid model","volume":"10","author":"Pilla","year":"2021","journal-title":"Pathogens"},{"issue":"11","key":"10.1016\/j.lfs.2022.121332_bb0265","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1021\/acs.molpharmaceut.2c00378","article-title":"Stable recombinant invasion plasmid antigen C (IpaC)-based single dose nanovaccine for shigellosis","volume":"19","author":"Baruah","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.lfs.2022.121332_bb0270","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1016\/j.vaccine.2017.09.045","article-title":"Vaccines against Shigella and enterotoxigenic Escherichia coli: a summary of the 2016 VASE Conference","volume":"35","author":"Walker","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb0275","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cmi.2018.06.023","article-title":"Update on vaccines for enteric pathogens","volume":"24","author":"Riddle","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.lfs.2022.121332_bb0280","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1016\/j.vaccine.2005.07.013","article-title":"Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model","volume":"24","author":"Barry","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.204","article-title":"Deletion of toxin\u2013antitoxin systems in the evolution of Shigella sonnei as a host-adapted pathogen","volume":"2","author":"McVicker","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0290","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1586\/14787210.2014.970634","article-title":"Melioidosis: molecular aspects of pathogenesis","volume":"12","author":"Stone","year":"2014","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.lfs.2022.121332_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.135040","article-title":"Enhancing antibacterial immunotherapy for bacterial pneumonia via nanovaccines coated with outer membrane vesicles","volume":"436","author":"Wu","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.lfs.2022.121332_bb0300","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2147\/IJN.S350846","article-title":"Outer membrane vesicles coating nano-glycyrrhizic acid confers protection againstBorderella bronchiseptica through Th1\/Th2\/Th17 responses","volume":"17","author":"Huang","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.lfs.2022.121332_bb0305","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Outer-membrane vesicles from gram-negative bacteria: biogenesis and functions","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0310","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.biotechadv.2017.05.003","article-title":"Bioengineering bacterial outer membrane vesicles as vaccine platform","volume":"35","author":"Gerritzen","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.lfs.2022.121332_bb0315","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/vaccines5040049","article-title":"A Burkholderia pseudomallei outer membrane vesicle vaccine provides cross protection against inhalational glanders in mice and non-human primates","volume":"5","author":"Baker","year":"2017","journal-title":"Vaccines"},{"key":"10.1016\/j.lfs.2022.121332_bb0320","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CVI.00119-14","article-title":"A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis","volume":"21","author":"Nieves","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-021-00281-z","article-title":"Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine","volume":"6","author":"Baker","year":"2021","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.lfs.2022.121332_bb0330","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coi.2017.06.007","article-title":"BCG\u2014old workhorse, new skills","volume":"47","author":"Gengenbacher","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0335","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/pharmaceutics12090848","article-title":"Preclinical progress of subunit and live attenuated Mycobacterium tuberculosis vaccines: a review following the first in human efficacy trial","volume":"12","author":"Watt","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2022.121332_bb0340","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1016\/j.vaccine.2021.06.049","article-title":"MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG","volume":"39","author":"Mart\u00edn","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb0345","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb0350","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mjafi.2018.12.013","article-title":"Current trends in tuberculosis vaccine","volume":"75","author":"Soundarya","year":"2019","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.lfs.2022.121332_bb0355","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: a new chance to shorten the treatment of latent tuberculosis infection","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis"},{"key":"10.1016\/j.lfs.2022.121332_bb0360","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/occmed\/kqm110","article-title":"Active and passive immunity, vaccine types, excipients and licensing","volume":"57","author":"Baxter","year":"2007","journal-title":"Occup. Med. (Chic. Ill)"},{"key":"10.1016\/j.lfs.2022.121332_bb0365","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fimmu.2021.653092","article-title":"Subunit vaccines using TLR triagonist combination adjuvants provide protection against Coxiella burnetii while minimizing reactogenic responses","volume":"12","author":"Fratzke","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0370","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2352-4642(21)00311-4","article-title":"Global, regional, and national causes of under-5 mortality in 2000\u201319: an updated systematic analysis with implications for the sustainable development goals","volume":"6","author":"Perin","year":"2022","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.lfs.2022.121332_bb0375","doi-asserted-by":"crossref","first-page":"21460","DOI":"10.1002\/jcp.28870","article-title":"Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection","volume":"234","author":"Keikha","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.12980\/jclm.5.2017J6-238","article-title":"Co-infection of Helicobacter pylori and Escherichia coli in a 4-year-old child","volume":"5","author":"Heidarzadeh","year":"2017","journal-title":"J. Coast. Life Med."},{"key":"10.1016\/j.lfs.2022.121332_bb0385","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.vaccine.2012.04.002","article-title":"Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine","volume":"30","author":"Riordan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb0390","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(99)70063-6","article-title":"Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori\u2013infected adults","volume":"116","author":"Michetti","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2022.121332_bb0395","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/IAI.00174-10","article-title":"A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice","volume":"78","author":"Wieser","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2011.00797.x","article-title":"Escherichia coli from animal reservoirs as a potential source of human extraintestinal pathogenic E. coli","volume":"62","author":"B\u00e9langer","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0405","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1286-4579(03)00049-2","article-title":"Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem","volume":"5","author":"Russo","year":"2003","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2022.121332_bb0410","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1128\/IAI.01269-06","article-title":"Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli","volume":"75","author":"Durant","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb0415","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00022-22","article-title":"Preclinical immunogenicity and efficacy of optimized O25b O-antigen glycoconjugates to prevent MDR ST131 E. coli infections","volume":"90","author":"Chorro","year":"2022","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb0420","series-title":"Production and Delivery of Recombinant Subunit Vaccines","author":"Andersson","year":"2000"},{"key":"10.1016\/j.lfs.2022.121332_bb0425","series-title":"Novel Subunit and Live Vaccine Strategies to Protect Against Tuberculosis","author":"Nisa","year":"2018"},{"key":"10.1016\/j.lfs.2022.121332_bb0430","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018553","article-title":"Risk of pneumococcal diseases in adults with underlying medical conditions: a retrospective, cohort study using two Japanese healthcare databases","volume":"8","author":"Imai","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.lfs.2022.121332_bb0435","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb0440","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2022.121332_bb0445","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00438-13","article-title":"Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease","volume":"4","author":"Marks","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.lfs.2022.121332_bb0450","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1128\/IAI.00488-12","article-title":"Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo","volume":"80","author":"Marks","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113867","article-title":"Prophylactic vaccine delivery systems against epidemic infectious diseases","volume":"176","author":"Pan","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2022.121332_bb0460","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1073\/pnas.1603007113","article-title":"Directed vaccination against pneumococcal disease","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2022.121332_bb0465","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1701797","article-title":"Comprehensive vaccine design for commensal disease progression","volume":"3","author":"Jones","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2022.121332_bb0470","series-title":"Microb. Technol. Welf. Soc","first-page":"223","article-title":"Molecular diagnosis of acute and chronic brucellosis in humans","author":"Dadar","year":"2019"},{"key":"10.1016\/j.lfs.2022.121332_bb0475","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3389\/fmicb.2016.01557","article-title":"Brucella abortus strain 2308 Wisconsin genome: importance of the definition of reference strains","volume":"7","author":"Su\u00e1rez-Esquivel","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0480","first-page":"1","article-title":"Brucellosis control methods with an emphasis on vaccination: a systematic review","author":"Darbandi","year":"2022","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.lfs.2022.121332_bb0485","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.micpath.2012.11.011","article-title":"Lipopolysaccharide as a target for brucellosis vaccine design","volume":"58","author":"Conde-\u00c1lvarez","year":"2013","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.lfs.2022.121332_bb0490","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/IAI.72.4.2081-2087.2004","article-title":"Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells","volume":"72","author":"Munoz-Montesino","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb0495","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/vaccines8040680","article-title":"Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats","volume":"8","author":"Vrba","year":"2020","journal-title":"Vaccines."},{"key":"10.1016\/j.lfs.2022.121332_bb0500","first-page":"51","article-title":"Live vaccines","author":"Shaw","year":"2001","journal-title":"New Vaccine Technol."},{"key":"10.1016\/j.lfs.2022.121332_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-11-69","article-title":"Influenza viral vectors expressing the Brucella OMP16 or L7\/L12 proteins as vaccines against B. abortus infection","volume":"11","author":"Tabynov","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.lfs.2022.121332_bb0510","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40249-021-00801-y","article-title":"A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model","volume":"10","author":"Bugybayeva","year":"2021","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.lfs.2022.121332_bb0515","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/pathogens11040443","article-title":"Salmonella enteritidis subunit vaccine candidate based on SseB protein co-delivered with simvastatin as adjuvant","volume":"11","author":"Kang","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.lfs.2022.121332_bb0520","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijfoodmicro.2016.01.020","article-title":"Phenotypic characteristics and genotypic correlation between Salmonella isolates from a slaughterhouse and retail markets in Yangzhou, China","volume":"222","author":"Cai","year":"2016","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0525","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.micpath.2015.01.002","article-title":"Decrease of colonization in the chicks'cecum and internal organs of Salmonella enterica serovar pullorum by deletion of cpdB by red system","volume":"80","author":"Liu","year":"2015","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.lfs.2022.121332_bb0530","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/03079450903183645","article-title":"Efficacy of several vaccination programmes in commercial layer and broiler breeder hens against experimental challenge with Salmonella enterica serovar Enteritidis","volume":"38","author":"Filho","year":"2009","journal-title":"Avian Pathol."},{"key":"10.1016\/j.lfs.2022.121332_bb0535","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4110\/in.2015.15.1.27","article-title":"Protection against Salmonella typhimurium, Salmonella gallinarum, and Salmonella enteritidis infection in layer chickens conferred by a live attenuated Salmonella typhimurium strain","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw."},{"key":"10.1016\/j.lfs.2022.121332_bb0540","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.4049\/jimmunol.180.9.6159","article-title":"A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection","volume":"180","author":"Yang","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0545","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/pharmaceutics12050418","article-title":"Nanoparticles to improve the efficacy of vaccines","volume":"12","author":"Yun","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2022.121332_bb0550","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.actbio.2019.03.049","article-title":"Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection","volume":"90","author":"Kye","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.lfs.2022.121332_bb0555","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/14760584.6.5.685","article-title":"Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation","volume":"6","author":"Hem","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.lfs.2022.121332_bb0560","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"key":"10.1016\/j.lfs.2022.121332_bb0565","doi-asserted-by":"crossref","first-page":"230","DOI":"10.7150\/jca.1.230","article-title":"Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens","volume":"1","author":"Lokhov","year":"2010","journal-title":"J. Cancer"},{"key":"10.1016\/j.lfs.2022.121332_bb0570","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.syapm.2014.12.004","article-title":"Emendation of the family Chlamydiaceae: proposal of a single genus, Chlamydia, to include all currently recognized species","volume":"38","author":"Sachse","year":"2015","journal-title":"Syst. Appl. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0575","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1016\/j.vaccine.2017.01.023","article-title":"Status of vaccine research and development of vaccines for Chlamydia trachomatis infection","volume":"37","author":"Poston","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102257","article-title":"A nanovaccine formulation of chlamydia recombinant MOMP encapsulated in PLGA 85: 15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice","volume":"29","author":"Sahu","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.lfs.2022.121332_bb0585","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3389\/fimmu.2021.660932","article-title":"Encapsulation of recombinant MOMP in extended-releasing PLGA 85: 15 nanoparticles confer protective immunity against a chlamydia muridarum genital challenge and re-challenge","volume":"12","author":"Sahu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0590","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ymthe.2017.12.016","article-title":"Nanoparticle-fusion protein complexes protect against Mycobacterium tuberculosis infection","volume":"26","author":"Hart","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2022.121332_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.03.020","article-title":"Advancements in prophylactic and therapeutic nanovaccines","volume":"108","author":"Bhardwaj","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.lfs.2022.121332_bb0600","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.lfs.2022.121332_bb0605","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1073\/pnas.81.18.5849","article-title":"The cloned genome of ground squirrel hepatitis virus is infectious in the animal","volume":"81","author":"Seeger","year":"1984","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2022.121332_bb0610","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response","volume":"356","author":"Tang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2022.121332_bb0615","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.lfs.2022.121332_bb0620","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1073\/pnas.95.16.9482","article-title":"Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo","volume":"95","author":"Fields","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2022.121332_bb0625","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.159.1.11","article-title":"The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites","volume":"159","author":"Iwasaki","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006566","article-title":"Long-read whole genome sequencing and comparative analysis of six strains of the human pathogen Orientia tsutsugamushi","volume":"12","author":"Batty","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb0635","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1128\/JCM.01526-10","article-title":"Isolation of a novel Orientia species (O. chuto sp. nov.) from a patient infected in Dubai","volume":"48","author":"Izzard","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0640","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1089\/vbz.2012.1155","article-title":"Molecular phylogenetic analysis of Orientia tsutsugamushi based on the groES and groEL genes","volume":"13","author":"Arai","year":"2013","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb0645","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/vbz.2012.1112","article-title":"Diversity of the 47-kD HtrA nucleic acid and translated amino acid sequences from 17 recent human isolates of Orientia","volume":"13","author":"Jiang","year":"2013","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb0650","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4269\/ajtmh.2010.09-0608","article-title":"Phylogenetic analysis of 56-kDa type-specific antigen gene of Orientia tsutsugamushi isolates in Taiwan","volume":"83","author":"Lu","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.lfs.2022.121332_bb0655","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1080\/21645515.2020.1834807","article-title":"Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study","volume":"17","author":"Eldridge","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.lfs.2022.121332_bb0660","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.lfs.2022.121332_bb0665","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1365-2958.2002.02915.x","article-title":"Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection","volume":"44","author":"Hung","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0670","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1111\/j.1462-5822.2007.00952.x","article-title":"Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili","volume":"9","author":"Wright","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.196","article-title":"A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease","volume":"2","author":"O'brien","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0680","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/315258","article-title":"Vaccination with fimh adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Eschevichia coli","volume":"181","author":"Langermann","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb0685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022663","article-title":"Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model","volume":"6","author":"Pore","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121332_bb0690","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.vaccine.2019.04.053","article-title":"Oral immunization with LacVax\u00ae OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model","volume":"37","author":"Yagnik","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb0695","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.micinf.2016.09.002","article-title":"Shigellosis murine model established by intraperitoneal and intranasal route of administration: a comparative comprehension overview","volume":"19","author":"Sharma","year":"2017","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2022.121332_bb0700","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015072","article-title":"Identification, activity and disulfide connectivity of C-di-GMP regulating proteins in Mycobacterium tuberculosis","volume":"5","author":"Gupta","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121332_bb0705","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijid.2016.10.018","article-title":"Novel approaches to tuberculosis vaccine development","volume":"56","author":"Kaufmann","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb0710","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1016\/j.vaccine.2016.08.035","article-title":"The BCG\u0394BCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo","volume":"34","author":"Pedroza-Rold\u00e1n","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb0715","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/iub.1353","article-title":"The cyclic di-GMP phosphodiesterase gene R v1357c\/BCG 1419c affects BCG pellicle production and in vivo maintenance","volume":"67","author":"Flores-Valdez","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.lfs.2022.121332_bb0720","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/1040841X.2016.1249335","article-title":"Vi capsular polysaccharide: synthesis, virulence, and application","volume":"43","author":"Hu","year":"2017","journal-title":"Crit. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121332_bb0725","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","article-title":"Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden","volume":"10","author":"Gon\u00e7alves","year":"2022","journal-title":"<sb:contribution><sb:title>Lancet<\/sb:title><\/sb:contribution><sb:host><sb:issue><sb:series><sb:title>Glob. Health<\/sb:title><\/sb:series><\/sb:issue><\/sb:host>"},{"key":"10.1016\/j.lfs.2022.121332_bb0730","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/vaccines7010018","article-title":"Complementary role of CD4+ T cells in response to pneumococcal polysaccharide vaccines in humans","volume":"7","author":"Jha","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.lfs.2022.121332_bb0735","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1241146","article-title":"Diversity among memory B cells: origin, consequences, and utility","volume":"341","author":"Tarlinton","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.lfs.2022.121332_bb0740","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4049\/jimmunol.1800840","article-title":"HBHA-induced polycytotoxic CD4+ T lymphocytes are associated with the control of Mycobacterium tuberculosis infection in humans","volume":"202","author":"Aerts","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0745","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1586\/14760584.2015.1102638","article-title":"Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines","volume":"14","author":"Mascart","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.lfs.2022.121332_bb0750","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nm1090","article-title":"Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin","volume":"10","author":"Temmerman","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2022.121332_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000926","article-title":"Heparin-binding-hemagglutinin-induced IFN-\u03b3 release as a diagnostic tool for latent tuberculosis","volume":"2","author":"Hougardy","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121332_bb0760","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1164\/rccm.201509-1746OC","article-title":"Lipoarabinomannan-responsive polycytotoxic T cells are associated with protection in human tuberculosis","volume":"194","author":"Busch","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2022.121332_bb0765","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nm.4023","article-title":"Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites","volume":"22","author":"Dotiwala","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2022.121332_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052487","article-title":"Matched-cohort DNA microarray diversity analysis of methicillin sensitive and methicillin resistant Staphylococcus aureus isolates from hospital admission patients","volume":"7","author":"Ruffing","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121332_bb0775","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4161\/hv.34414","article-title":"Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: phase III randomized study","volume":"11","author":"Fattom","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.lfs.2022.121332_bb0780","first-page":"1","article-title":"Protective humoral and CD4+ T cellular immune responses of Staphylococcus aureus vaccine MntC in a murine peritonitis model","volume":"8","author":"Yu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.121332_bb0785","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.lfs.2022.121332_bb0790","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fcimb.2012.00016","article-title":"Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials","volume":"2","author":"Bagnoli","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0795","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0002-9343(88)80337-1","article-title":"Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex","volume":"85","author":"Jacobson","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1016\/j.lfs.2022.121332_bb0800","first-page":"57","article-title":"X-linked agammaglobulinemia in northern Thailand","volume":"24","author":"Trakultivakorn","year":"2006","journal-title":"Asian Pac.J. Allergy Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109591","article-title":"B cells promote CD8 T cell primary and memory responses to subunit vaccines","volume":"36","author":"Klarquist","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2022.121332_bb0810","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1086\/518140","article-title":"Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans","volume":"45","author":"Sztein","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb0815","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029546","article-title":"Is a human CD8 T-cell vaccine possible, and if so, what would it take? CD8 T-cell-mediated protective immunity and vaccination against enteric bacteria","volume":"10","author":"Sztein","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.lfs.2022.121332_bb0820","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fimmu.2017.00208","article-title":"Importance of Salmonella Typhi-responsive CD8+ T cell immunity in a human typhoid fever challenge model","volume":"8","author":"Fresnay","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0825","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fimmu.2014.00381","article-title":"Identification of protective antigens for vaccination against systemic salmonellosis","volume":"5","author":"Bumann","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0830","series-title":"Immunity to Intracellular Salmonella Depends on Surface-associated Antigens","author":"Barat","year":"2012"},{"key":"10.1016\/j.lfs.2022.121332_bb0835","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.4049\/jimmunol.173.9.5852","article-title":"Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine","volume":"173","author":"Salerno-Gon\u00e7alves","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0840","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4049\/jimmunol.160.1.376","article-title":"Chronic Listeria infection in SCID mice: requirements for the carrier state and the dual role of T cells in transferring protection or suppression","volume":"160","author":"Bhardwaj","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0845","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fmb-2016-0221","article-title":"How the study of Listeria monocytogenes has led to new concepts in biology","volume":"12","author":"Rolhion","year":"2017","journal-title":"Future Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0850","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/eji.200838718","article-title":"The cellular niche of Listeria monocytogenes infection changes rapidly in the spleen","volume":"39","author":"Aoshi","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009493","article-title":"Phagocytes produce prostaglandin E2 in response to cytosolic Listeria monocytogenes","volume":"17","author":"McDougal","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2022.121332_bb0860","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/microorganisms9050973","article-title":"Differential immune response following intranasal and intradermal infection with Francisella tularensis: implications for vaccine development","volume":"9","author":"Nicol","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.lfs.2022.121332_bb0865","series-title":"Effector Responses of Cytotoxic CD8+ T Cells Generated by Utilizing an FcR-targeting Vaccine Strategy in an Intracellular Bacterial Infection Model","author":"Bitsaktsis","year":"2018"},{"key":"10.1016\/j.lfs.2022.121332_bb0870","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007160","article-title":"Antibody to poly-N-acetyl glucosamine provides protection against intracellular pathogens: mechanism of action and validation in horse foals challenged with Rhodococcus equi","volume":"14","author":"Cywes-Bentley","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2022.121332_bb0875","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/sji.12465","article-title":"Global efforts in the development of vaccines for tuberculosis: requirements for improved vaccines against Mycobacterium tuberculosis","volume":"84","author":"M\u00e9ndez-Samperio","year":"2016","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0880","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cveq.2014.08.010","article-title":"Rhodococcus equi foal pneumonia","volume":"30","author":"Cohen","year":"2014","journal-title":"Vet. Clin. Equine Pract."},{"key":"10.1016\/j.lfs.2022.121332_bb0885","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cveq.2014.11.004","article-title":"Update on bacterial pneumonia in the foal and weanling","volume":"31","author":"Reuss","year":"2015","journal-title":"Vet. Clin. Equine Pract."},{"key":"10.1016\/j.lfs.2022.121332_bb0890","doi-asserted-by":"crossref","first-page":"E2209","DOI":"10.1073\/pnas.1303573110","article-title":"Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens","volume":"110","author":"Cywes-Bentley","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2022.121332_bb0895","first-page":"3","article-title":"Innate and adaptive immune responses during Listeria monocytogenes infection","volume":"7","author":"D'Orazio","year":"2019","journal-title":"Microbiol. Spectr."},{"issue":"5","key":"10.1016\/j.lfs.2022.121332_bb0900","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1111\/jam.15496","article-title":"The combination of thymol and cinnamaldehyde reduces the survival and virulence of Listeria monocytogenes on autoclaved chicken breast","volume":"132","author":"Liang","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0905","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00253-018-09605-x","article-title":"Expression of the VP1 protein of FMDV integrated chromosomally with mutant Listeria monocytogenes strain induced both humoral and cellular immune responses","volume":"103","author":"Mahdy","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.lfs.2022.121332_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2019.113722","article-title":"Development of a recombinant vaccine against foot and mouth disease utilizing mutant attenuated Listeria ivanovii strain as a live vector","volume":"273","author":"Mahdy","year":"2019","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.lfs.2022.121332_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2019.108447","article-title":"Rough Brucella neotomae provides protection against Brucella suis challenge in mice","volume":"239","author":"Jain-Gupta","year":"2019","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0920","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1016\/j.vaccine.2019.05.084","article-title":"The advances in brucellosis vaccines","volume":"37","author":"Hou","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb0925","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-1135(02)00252-3","article-title":"Epidemiology and control of brucellosis in China","volume":"90","author":"Deqiu","year":"2002","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0930","unstructured":"A. Shil P. Dey T.K. Mandal Brucellosis and Its Treatment: An Overview, J. Homepage Www. Ijrpr. Com ISSN. 2582 (n.d.) 7421."},{"key":"10.1016\/j.lfs.2022.121332_bb0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-016-3076-5","article-title":"Comparative genomic analysis between newly sequenced Brucella suis Vaccine Strain S2 and the Virulent Brucella suis Strain 1330","volume":"17","author":"Di","year":"2016","journal-title":"BMC Genomics"},{"key":"10.1016\/j.lfs.2022.121332_bb0940","first-page":"4067","article-title":"Dihydroartemisinin inhibits multiplication of Brucella suis vaccine strain 2 in murine microglia BV2 cells via stimulation of caspase-dependent apoptosis","volume":"20","author":"Yang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2022.121332_bb0945","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1574-6976.2012.00334.x","article-title":"Internal affairs: investigating the Brucella intracellular lifestyle","volume":"36","author":"vonBargen","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.lfs.2022.121332_bb0950","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.vaccine.2013.06.078","article-title":"Protection to respiratory challenge of Brucella abortus strain 2308 in the lung","volume":"31","author":"Surendran","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb0955","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3389\/fimmu.2019.01775","article-title":"The BtaF adhesin is necessary for full virulence during respiratory infection by Brucella suis and is a novel immunogen for nasal vaccination against Brucella infection","author":"Mu\u00f1oz Gonz\u00e1lez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-017-0010-z","article-title":"Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection","volume":"2","author":"Sanchez Alberti","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.lfs.2022.121332_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2021.100255","article-title":"Molecular characterization and antimicrobial susceptibility testing of clinical and non-clinical Brucella melitensis and Brucella abortus isolates from Egypt","volume":"13","author":"Wareth","year":"2021","journal-title":"One Health"},{"key":"10.1016\/j.lfs.2022.121332_bb0970","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/1348-0421.12850","article-title":"The candidate vaccine strain Brucella ovis\u2206 abcBA is protective against Brucella melitensis infection in mice","volume":"64","author":"Costa","year":"2020","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106573","article-title":"Evaluation of poly (I: C) and combination of CpG ODN plus montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice","volume":"84","author":"Golshani","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2022.121332_bb0980","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7883\/yoken.JJID.2016.133","article-title":"Clinical and diagnostic aspects of brucellosis and antimicrobial susceptibility of Brucella isolates in Hamedan, Iran","volume":"70","author":"Asadi","year":"2017","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb0985","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fcimb.2012.00002","article-title":"Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics","volume":"2","author":"He","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb0990","article-title":"Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121332_bb0995","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb1000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016203","article-title":"An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice","volume":"6","author":"Pasquevich","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121332_bb1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2016.04.016","article-title":"A novel recombinant multi-epitope protein against Brucella melitensis infection","volume":"175","author":"Yin","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.lfs.2022.121332_bb1010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015964","article-title":"Complete sequencing and pan-genomic analysis of Lactobacillus delbrueckii subsp. bulgaricus reveal its genetic basis for industrial yogurt production","volume":"6","author":"Hao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121332_bb1015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.micpath.2018.09.033","article-title":"Reverse vaccinology and subtractive genomics-based putative vaccine targets identification for Burkholderia pseudomallei Bp1651","volume":"125","author":"Nazir","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.lfs.2022.121332_bb1020","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.ygeno.2019.10.009","article-title":"Potential druggable proteins and chimeric vaccine construct prioritization against Brucella melitensis from species core genome data","volume":"112","author":"Aslam","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.lfs.2022.121332_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105829","article-title":"Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I: C against Brucella melitensis and Brucella abortus infection","volume":"75","author":"Sadeghi","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2022.121332_bb1030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13567-015-0199-7","article-title":"Recent advances in Brucella abortus vaccines","volume":"46","author":"Dorneles","year":"2015","journal-title":"Vet. Res."},{"key":"10.1016\/j.lfs.2022.121332_bb1035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jbiotec.2020.01.016","article-title":"Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection","volume":"310","author":"Sadeghi","year":"2020","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.lfs.2022.121332_bb1040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2478\/jccm-2019-0013","article-title":"Cervical spine spondylitis with an epidural abscess in a patient with brucellosis: a case report","volume":"5","author":"Roushan","year":"2019","journal-title":"J. Crit. Care Med."},{"key":"10.1016\/j.lfs.2022.121332_bb1045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/vr.108.5.90","article-title":"Characterisation of Brucella abortus strain 19 cultures isolated from vaccinated cattle","volume":"108","author":"Thomas","year":"1981","journal-title":"Vet. Rec."},{"key":"10.1016\/j.lfs.2022.121332_bb1050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146521","article-title":"The genome sequence of Brucella abortus vaccine strain A19 provides insights on its virulence attenuation compared to Brucella abortus strain 9\u2013941","volume":"830","author":"Wang","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.lfs.2022.121332_bb1060","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00822-19","article-title":"Interaction of Brucella abortus with osteoclasts: a step toward understanding osteoarticular brucellosis and vaccine safety","volume":"88","author":"Khalaf","year":"2020","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb1065","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/421746","article-title":"Biology of bone tissue: structure, function, and factors that influence bone cells","volume":"2015","author":"Florencio-Silva","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2022.121332_bb1070","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1128\/IAI.01366-12","article-title":"Brucella abortus invasion of synoviocytes inhibits apoptosis and induces bone resorption through RANKL expression","volume":"81","author":"Scian","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb1075","series-title":"Medical Microbiology","volume":"4","author":"Ryan","year":"2004"},{"key":"10.1016\/j.lfs.2022.121332_bb1080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.1997.03550050074036","article-title":"Biological warfare: a historical perspective","volume":"278","author":"Christopher","year":"1997","journal-title":"Jama"},{"key":"10.1016\/j.lfs.2022.121332_bb1085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fcimb.2018.00115","article-title":"Adaptive immunity to Francisella tularensis and considerations for vaccine development","volume":"8","author":"Roberts","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb1090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7774\/cevr.2013.2.1.34","article-title":"Current status of vaccine development for tularemia preparedness","volume":"2","author":"Hong","year":"2013","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.lfs.2022.121332_bb1095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.micpath.2004.04.005","article-title":"Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis","volume":"37","author":"Shen","year":"2004","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.lfs.2022.121332_bb1100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/IAI.01241-06","article-title":"The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens","volume":"75","author":"Thomas","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb1105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12223-016-0461-z","article-title":"Tularemia vaccines","volume":"61","author":"Putzova","year":"2016","journal-title":"Folia Microbiol. (Praha)"},{"key":"10.1016\/j.lfs.2022.121332_bb1110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.micpath.2007.08.009","article-title":"Protection afforded against aerosol challenge by systemic immunisation with inactivated francisella tularensis live vaccine strain (LVS)","volume":"44","author":"Eyles","year":"2008","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.lfs.2022.121332_bb1115","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1128\/IAI.01606-06","article-title":"Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion","volume":"75","author":"Baron","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb1120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/CMR.00018-07","article-title":"Melioidosis: epidemiology, pathophysiology, and management","volume":"20","author":"Cheng","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.lfs.2022.121332_bb1125","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro1385","article-title":"Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei","volume":"4","author":"Wiersinga","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb1130","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(03)13374-0","article-title":"Melioidosis","volume":"361","author":"White","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2022.121332_bb1135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fmicb.2011.00198","article-title":"Development of vaccines against Burkholderia pseudomallei","volume":"2","author":"Patel","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb1140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/bmb\/ldr007","article-title":"Melioidosis: a clinical overview","volume":"99","author":"Limmathurotsakul","year":"2011","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.lfs.2022.121332_bb1145","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1016\/j.vaccine.2017.03.022","article-title":"Burkholderia pseudomallei and Burkholderia mallei vaccines: are we close to clinical trials?","volume":"35","author":"Titball","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121332_bb1150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198906","article-title":"Immune response to recombinant Burkholderia pseudomallei FliC","volume":"13","author":"Koosakulnirand","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121332_bb1155","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1099\/jmm.0.47043-0","article-title":"Polysaccharides and virulence of Burkholderia pseudomallei","volume":"56","author":"Sarkar-Tyson","year":"2007","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.lfs.2022.121332_bb1160","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cei.13286","article-title":"Novel multi-component vaccine approaches for Burkholderia pseudomallei","volume":"196","author":"Morici","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2022.121332_bb1165","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/febs.13223","article-title":"From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK","volume":"282","author":"Gourlay","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2022.121332_bb1170","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1128\/IAI.01248-15","article-title":"Linocin and OmpW are involved in attachment of the cystic fibrosis-associated pathogen Burkholderia cepacia complex to lung epithelial cells and protect mice against infection","volume":"84","author":"McClean","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb1175","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/cells9122671","article-title":"Current advances in Burkholderia vaccines development","volume":"9","author":"Wang","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2022.121332_bb1180","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1080\/21505594.2017.1307485","article-title":"Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application","volume":"8","author":"Lankelma","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.lfs.2022.121332_bb1185","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1128\/IAI.74.3.1699-1705.2006","article-title":"CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB\/c mice","volume":"74","author":"Chen","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb1190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1865-1682.2012.01342.x","article-title":"Glanders in animals: a review on epidemiology, clinical presentation, diagnosis and countermeasures","volume":"60","author":"Khan","year":"2013","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb1195","first-page":"1","article-title":"Glanders: an overview of infection in humans","volume":"8","author":"VanZandt","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.lfs.2022.121332_bb1200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s40475-015-0042-2","article-title":"Recent advances in Burkholderia mallei and B.pseudomallei research","volume":"2","author":"Hatcher","year":"2015","journal-title":"Curr. Trop. Med. Rep."},{"key":"10.1016\/j.lfs.2022.121332_bb1205","doi-asserted-by":"crossref","first-page":"e00102","DOI":"10.1128\/IAI.00102-17","article-title":"Antibodies against in vivo-expressed antigens are sufficient to protect against lethal aerosol infection with Burkholderia mallei and Burkholderia pseudomallei","volume":"85","author":"Zimmerman","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb1210","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1073\/pnas.0812080106","article-title":"A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens","volume":"106","author":"Felgner","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2022.121332_bb1215","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00724-17","article-title":"Development of subunit vaccines that provide high-level protection and sterilizing immunity against acute inhalational melioidosis","volume":"86","author":"Burtnick","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121332_bb1220","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00570-18","article-title":"Burkholderia pseudomallei \u0394 tonB \u0394 hcp1 live attenuated vaccine strain elicits full protective immunity against aerosolized melioidosis infection","volume":"4","author":"Khakhum","year":"2019","journal-title":"Msphere"},{"key":"10.1016\/j.lfs.2022.121332_bb1225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-020-00229-9","article-title":"Multicomponent gold nano-glycoconjugate as a highly immunogenic and protective platform against Burkholderia mallei","volume":"5","author":"Tapia","year":"2020","journal-title":"Npj Vaccines"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522010323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522010323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:52:44Z","timestamp":1736315564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522010323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":245,"alternative-id":["S0024320522010323"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121332","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121332"}}